In a survey of 377 buprenorphine prescribers in Michigan, high-threshold practices such as requiring counseling as a condition for buprenorphine treatment and conducting drug testing during every in-office visit were associated with higher rates of treatment termination for patients receiving buprenorphine. Buprenorphine treatment continuity is critical to preventing overdose deaths amidst an intensifying national overdose crisis. State policy reforms encouraging practices to retain patients in treatment even if they do not strictly adhere to counseling recommendations and limiting drug testing to a clinically relevant frequency could improve overall patient engagement with buprenorphine treatment and save lives.
Published January 16, 2024
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
2024 Activity Report – Brazil
Estimação do impacto de diferentes cenários de redução do consumo de álcool no…
Estimation of the impact of various scenarios of reduction of alcohol use in…
Relatório de Atividades 2024 – Brasil
The Future of Health Financing in Africa: The Role of Health Taxes
RESET Alcohol Initiative Case Study: Media Campaign Resonates with the Public in Mexico
RESET Alcohol Initiative Case Study: A Historic Win for Alcohol Policy in Brazil
Effects of Heat on Early Childhood Development
Blood Lead Surveillance of Children and Pregnant Women in Tamil Nadu, India
Sportswashing through Media: Coca-Cola’s Olympic Play – A Research Report